Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
Harvard University, Joslin Diabetes Center
mi
from
Boston, MA
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
Harvard University, Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
University of Virginia, Center for Diabetes Technology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center (University of Colorado)
mi
from
Aurora, CO
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center (University of Colorado)
mi
from
Aurora, CO
Click here to add this to my saved trials
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated:  12/31/1969
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Status: Enrolling
Updated: 12/31/1969
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 10
mi
from
Montclair, CA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 10
mi
from
Montclair, CA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 210
mi
from
Coral Gables, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 210
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 18
mi
from
Cleveland, OH
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 18
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 27
mi
from
Chula Vista, CA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 27
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 27
mi
from
La Mesa, CA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 27
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 383
mi
from
North Hollywood, CA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 383
mi
from
North Hollywood, CA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 12
mi
from
Miami Beach, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 12
mi
from
Miami Beach, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 8400116
mi
from
Miami, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 8400116
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 387
mi
from
Las Vegas, NV
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 387
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 361
mi
from
San Antonio, TX
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 361
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 332
mi
from
Anniston, AL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 332
mi
from
Anniston, AL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 16101
mi
from
Birmingham, AL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 16101
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 19
mi
from
DeLand, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 19
mi
from
DeLand, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 15
mi
from
Orlando, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 15
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 16
mi
from
Saint Petersburg, FL
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 16
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 21
mi
from
Peachtree Corners, GA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 21
mi
from
Peachtree Corners, GA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 17
mi
from
Snellville, GA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 17
mi
from
Snellville, GA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 20
mi
from
North Dartmouth, MA
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 20
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Study Site 30
mi
from
Caro, MI
A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Study Site 30
mi
from
Caro, MI
Click here to add this to my saved trials
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Specialty Care
mi
from
Jacksonville, FL
The Insulin-Only Bionic Pancreas Bridging Study
The Insulin-Only Bionic Pancreas Bridging Study
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Specialty Care
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
Reducing Postprandial Hyperglycemia With Adjuvant Premeal Pramlintide and Postmeal Insulin in Children With Type 1 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
Reducing Postprandial Hyperglycemia With Adjuvant Premeal Pramlintide and Postmeal Insulin in Children With Type 1 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
A Phase 2a, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Way Crossover Study to Compare Safety, Efficacy, and Pharmacodynamics of Single and Multiple Doses of ORMD-0801 in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
mi
from
Tustin, CA
A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
A Phase 2a, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Way Crossover Study to Compare Safety, Efficacy, and Pharmacodynamics of Single and Multiple Doses of ORMD-0801 in Adult Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
Feasibility Evaluation of an Artificial Pancreas With an Enhanced Model Predictive Control (eMPC) Controller and a Health Monitoring System (HMS) With a Glucose Prediction Trust Index
Status: Enrolling
Updated:  12/31/1969
William Sansum Diabetes Center
mi
from
Santa Barbara, CA
Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index
Feasibility Evaluation of an Artificial Pancreas With an Enhanced Model Predictive Control (eMPC) Controller and a Health Monitoring System (HMS) With a Glucose Prediction Trust Index
Status: Enrolling
Updated: 12/31/1969
William Sansum Diabetes Center
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Taking on Diabetes to Advance You (TODAY)
Taking on Diabetes to Advance You
Status: Enrolling
Updated:  12/31/1969
Family Medicine Center
mi
from
Fort Collins, CO
Taking on Diabetes to Advance You (TODAY)
Taking on Diabetes to Advance You
Status: Enrolling
Updated: 12/31/1969
Family Medicine Center
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Micro-mobile Foot Compression and Diabetic Foot
Micro-mobile Foot Compression Device to Improve Motor-function in People With Diabetes and Loss of Protective Sensation
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Micro-mobile Foot Compression and Diabetic Foot
Micro-mobile Foot Compression Device to Improve Motor-function in People With Diabetes and Loss of Protective Sensation
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Prediction Using Connected Technologies for Diabetes
Prediction Using a Randomized Evaluation of Data Collection Integrated Through Connected Technologies for Diabetes Management
Status: Enrolling
Updated:  12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Prediction Using Connected Technologies for Diabetes
Prediction Using a Randomized Evaluation of Data Collection Integrated Through Connected Technologies for Diabetes Management
Status: Enrolling
Updated: 12/31/1969
Penn Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
SGLT2 Inhibition in Diabetes and Heart Failure
SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
SGLT2 Inhibition in Diabetes and Heart Failure
SGLT2 Inhibition in Diabetic Patients With Heart Failure With Reduced Ejection Fraction
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Central Research Associates, Inc
mi
from
Birmingham, AL
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Central Research Associates, Inc
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
National Research Institute
mi
from
Los Angeles, CA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
National Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Rancho Cucamonga Clinical Trials
mi
from
Rancho Cucamonga, CA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Rancho Cucamonga Clinical Trials
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Sierra Clinical Research
mi
from
Roseville, CA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Sierra Clinical Research
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Encompass Clinical Research
mi
from
Spring Valley, CA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Encompass Clinical Research
mi
from
Spring Valley, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Premeir Clinical Research Institute
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Premeir Clinical Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
International Research Associates
mi
from
Miami, FL
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
International Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
CNS Healthcare
mi
from
Orlando, FL
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
CNS Healthcare
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Buynak Clinical Research, P.C.
mi
from
Valparaiso, IN
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Buynak Clinical Research, P.C.
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
MD Medical Research
mi
from
Oxon Hill, MD
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
MD Medical Research
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
AAMRC
mi
from
Flint, MI
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
AAMRC
mi
from
Flint, MI
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Prestige Clinical Research
mi
from
Franklin, OH
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Prestige Clinical Research
mi
from
Franklin, OH
Click here to add this to my saved trials